Search | TVST | ARVO Journals

Showing 1 – 20 of 59

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Single-Cell Transcriptomic Profiling Reveals Unique NKT Cell Infiltration-Related Gene Biomarkers Correlated with Survival Outcomes in Uveal Melanoma

Mona Meng Wang; Willie Yu; Sarah E Coupland; Anita Chan; Carlos R Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2233.

ARVO Annual Meeting Abstract June 2023

The tumor microenvironment influences response of uveal melanoma cells to FAK inhibitors (FAKi).

Karen Aughton; Joseph Sacco; Mark Devlin; Sarah E Coupland; Helen Kalirai

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):905.

ARVO Annual Meeting Abstract June 2023

Proteomic characterisation of the extracellular matrix in high metastatic risk uveal melanoma

Helen Kalirai; Karen Aughton; Sarah E Coupland

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):886.

ARVO Annual Meeting Abstract June 2023

Phosphoproteomic Analysis of Metastatic and Non-Metastatic Uveal Melanoma

Geeng-Fu Jang; Jack Crabb; Bo Hu; Belinda Willard; Helen Kalirai; Arun Singh; Sarah E Coupland; John W Crabb

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4488.

Ocular Oncology December 2022

Investigating the Role of DUSP4 in Uveal Melanoma

PDF

Karen Aughton; Dorota Sabat-Pośpiech; Samantha Barlow; Sarah E. Coupland; Helen Kalirai
TAGS: cell lines, doxorubicin, intraocular melanoma, proteins, selumetinib, rna, small interfering, mitogen-activated protein kinases, immunohistochemistry, phosphoric monoester hydrolases, bap1 gene
Trans. Vis. Sci. Tech.. 2022; 11(12):13. https://doi.org/10.1167/tvst.11.12.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

CysLT 1 antagonist, 1,4-dihydroxy quininib, alters the secretion of inflammatory mediators from primary uveal melanoma explants and reduces ATP5B expression in a metastatic xenograft model.

Kayleigh Slater; Rosa Bosch; Chowdhury Arif Jahangir; Arman Rahman; Fiona O'Connell; Josep M. Piulats; Sarah E Coupland; Valerie O'Neill; Noel Horgan; Jacintha O'Sullivan; William Gallagher; Alberto Villanueva; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2352 – A0021.

ARVO Annual Meeting Abstract June 2022

Integrative omics approach identifies druggable BAP1-dependencies in Uveal Melanoma

Luisa Silva; Sarah Barnett; Jenna Kenyani; Zohra Butt; Karen Aughton; Dean Hammond; Azzam Taktak; Joseph Sacco; Helen Kalirai; Sarah E Coupland; Judy Coulson

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2340 – A0009.

Articles March 2022

Vascular Lakes in Uveal Melanoma and Their Association With Outcome

PDF

Hayley Jones; Helen Kalirai; Azzam Taktak; Ke Chen; Sarah E. Coupland
TAGS: intraocular melanoma, patient prognosis, neoplasms
Trans. Vis. Sci. Tech.. 2022; 11(3):32. https://doi.org/10.1167/tvst.11.3.32

Anatomy and Pathology/Oncology November 2021

Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro

PDF

Revu V. L. Narayana; Pritikana Jana; Neha Tomar; Varsha Prabhu; Rohini M. Nair; Radhika Manukonda; Swathi Kaliki; Sarah E. Coupland; Jodi Alexander; Helen Kalirai; Anand K. Kondapi; Geeta K. Vemuganti
TAGS: cancer stem cells, carboplatin, culture media, conditioned, etoposide, lactoferrin, nanoparticles, proteins, retinoblastoma, drug release, cytotoxicity
Invest. Ophthalmol. Vis. Sci.. 2021; 62(14):13. https://doi.org/10.1167/iovs.62.14.13

Includes: Supplemental Content

Special Issue September 2020

Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections

PDF

Hongrun Zhang; Helen Kalirai; Amelia Acha-Sagredo; Xiaoyun Yang; Yalin Zheng; Sarah E. Coupland
TAGS: bap1 gene, deep learning, eosine yellowish-(ys), hematoxylin, intraocular melanoma, neoplasms, training
Trans. Vis. Sci. Tech.. 2020; 9(2):50. https://doi.org/10.1167/tvst.9.2.50

Includes: Supplemental Content

Anatomy and Pathology/Oncology August 2020

Melanoblasts Populate the Mouse Choroid Earlier in Development Than Previously Described

PDF

Paul G. McMenamin; Graham T. Shields; Yashar Seyed-Razavi; Helen Kalirai; Robert H. Insall; Laura M. Machesky; Sarah E. Coupland
TAGS: choroid, eye, mice, melanocytes, tyrosinase-related protein-2
Invest. Ophthalmol. Vis. Sci.. 2020; 61(10):33. https://doi.org/10.1167/iovs.61.10.33

Includes: Multimedia, Supplemental Content

Articles June 2020

Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture

PDF

Karen Aughton; Haleh Shahidipour; Luna Djirackor; Sarah E. Coupland; Helen Kalirai
TAGS: cell lines, intraocular melanoma, neoplasms, spheroids, cellular
Trans. Vis. Sci. Tech.. 2020; 9(7):39. https://doi.org/10.1167/tvst.9.7.39

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Melanocytes populate the mouse choroid earlier in development than previously described

Graham T. Shields; Yashar Seyed-Razavi; Helen Kalirai; Robert H. Insall; Laura M. Machesky; Sarah E. Coupland; Paul G. McMenamin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2237.

ARVO Annual Meeting Abstract June 2020

Cysteinyl leukotriene receptor 1 (CysLT 1 ) is associated with clinical parameters of uveal melanoma and CysLT receptor antagonists inhibit cancer hallmarks in vitro and in vivo

Kayleigh Slater; Aisling Heeran; Mays Helmi; Helen Kalirai; Sarah E Coupland; Alberto Villanueva; Rosa Bosch; Lasse Jensen; Josep Piulats; Jacintha O'Sullivan; Breandan N Kennedy

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2849.

Anatomy and Pathology/Oncology April 2020

Parsimonious Models for Predicting Mortality from Choroidal Melanoma

PDF

Bertil Damato; Antonio Eleuteri; Rumana Hussain; Helen Kalirai; Sophie Thornton; Azzam Taktak; Heinrich Heimann; Sarah E. Coupland
TAGS: malignant melanoma of choroid, mortality, neoplasms, patient prognosis, neoplasm metastasis, tnm tumor staging system, genetics, chromosomes, human, pair 3
Invest. Ophthalmol. Vis. Sci.. 2020; 61(4):35. https://doi.org/10.1167/iovs.61.4.35

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Phenotypic plasticity in uveal melanoma spheroids

Helen Kalirai; Luna Djirackor; Sarah E Coupland

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):729.

ARVO Annual Meeting Abstract July 2019

A 3D spheroid model of Uveal Melanoma (UM)

Luna Djirackor; Haleh Shahidipour; Sarah E Coupland; Helen Kalirai

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):730.

ARVO Annual Meeting Abstract July 2019

Validation of Choroid from Uveal Melanoma Eyes as Control Tissue for Proteomic Studies

Geeng-Fu Jang; Jack S Crabb; Bo Hu; Belinda Willard; Helen Kalirai; Arun D Singh; Sarah E Coupland; John W Crabb

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):747.

ARVO Annual Meeting Abstract July 2019

Using Mass-Cytometry approach for the characterisation of the microenvironment of primary uveal melanoma.

Carlos Rogerio De Figueiredo; Helen Kalirai; Joseph Sacco; Judy Coulson; Sarah E Coupland

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):748.

ARVO Annual Meeting Abstract July 2019

Transcriptomic analysis reveals genes and miRNAs dysregulated in high risk primary uveal melanoma.

Karen Aughton; Sarah L Lake; Louise Takeshita; Francesco Falciani; Helen Kalirai; Sarah E Coupland

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):753.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Single-Cell Transcriptomic Profiling Reveals Unique NKT Cell Infiltration-Related Gene Biomarkers Correlated with Survival Outcomes in Uveal Melanoma

The tumor microenvironment influences response of uveal melanoma cells to FAK inhibitors (FAKi).

Proteomic characterisation of the extracellular matrix in high metastatic risk uveal melanoma

Phosphoproteomic Analysis of Metastatic and Non-Metastatic Uveal Melanoma

Investigating the Role of DUSP4 in Uveal Melanoma

CysLT 1 antagonist, 1,4-dihydroxy quininib, alters the secretion of inflammatory mediators from primary uveal melanoma explants and reduces ATP5B expression in a metastatic xenograft model.

Integrative omics approach identifies druggable BAP1-dependencies in Uveal Melanoma

Vascular Lakes in Uveal Melanoma and Their Association With Outcome

Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro

Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections

Melanoblasts Populate the Mouse Choroid Earlier in Development Than Previously Described

Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture

Melanocytes populate the mouse choroid earlier in development than previously described

Cysteinyl leukotriene receptor 1 (CysLT 1 ) is associated with clinical parameters of uveal melanoma and CysLT receptor antagonists inhibit cancer hallmarks in vitro and in vivo

Parsimonious Models for Predicting Mortality from Choroidal Melanoma

Phenotypic plasticity in uveal melanoma spheroids

A 3D spheroid model of Uveal Melanoma (UM)

Validation of Choroid from Uveal Melanoma Eyes as Control Tissue for Proteomic Studies

Using Mass-Cytometry approach for the characterisation of the microenvironment of primary uveal melanoma.

Transcriptomic analysis reveals genes and miRNAs dysregulated in high risk primary uveal melanoma.

To View More...

You must be signed into an individual account to use this feature.